Dr. Nimesh Nagarsheth, MD

Bio

Dr. Nagarsheth graduated with honors (Alpha Omega Alpha) from Icahn School of Medicine at Mount Sinai. He completed his residency training in Obstetrics and Gynecology at Duke University Medical Center, and completed his fellowship in Gynecologic Oncology at Mount Sinai.  During his fellowship, he won numerous teaching, research, and clinical awards (including being recognized for his outstanding surgical skills by receiving first place in an international surgical film competition conducted by the prestigious American College of Obstetrics and Gynecology). During his training, Dr. Nagarsheth also conducted cutting-edge research at New York University Medical Center and Memorial Sloan-Kettering Cancer Center in New York. In his practice, Dr. Nagarsheth provides the full range of surgical and medical gynecologic oncology care.

His specialized interests include novel approaches to cancer management, cancer prevention, and advanced radical laparoscopic (minimally invasive) surgery including robotic surgery.  Dr. Nagarsheth has performed extensive research on the mechanisms of cancer prevention, including the hormonal manipulation of apoptosis. He is a lead author on a landmark study that provides the most convincing evidence yet for a novel theory of how birth control pills help prevent ovarian cancer. He has continued his research at Mount Sinai evaluating the role of hormonal effects on gynecologic organs, and has developed an extensive research background in blood management in the field of Gynecologic Oncology. Currently, Dr. Nagarsheth is considered one of the world's experts in performing Bloodless Surgery in Gynecologic Oncology. He speaks frequently at national meetings and serves as a principal investigator for several national clinical trials. Recently, Dr. Nagarsheth was invited by Fran Drescher (U.S. Public Diplomacy Envoy for Women's Health Issues, Founder and Visionary, Cancer Schmancer Movement, and television star) to serve on the medical advisory board for the Cancer Schmancer Movement.

In 2008, Dr. Nagarsheth joined together with five other Gynecologic Oncologists from around the country, with the support of the Gynecologic Cancer Foundation, and began an international campaign to raise awareness for gynecologic cancers through music and the arts. Dr. Nagarsheth and his talented colleagues formed the rock band N.E.D. (which stands for No Evidence of Disease) and landed a record deal with Motema Music, NYC. Their self-entitled album was released in September 2009  to rave reviews.

Dr. Nagarsheth also has been honored with a book deal from Jones and Bartlett Publishing and has written Music and Cancer, A Prescription for Healing. This book is receiving top reviews from prominent individuals ranging from celebrity cancer survivors to the Past President of the American Cancer Society and the Presidential Appointed Chair of the National Cancer Advisory Board. The book has been described as a 'must have' handbook for cancer patients and their caregivers. Proceeds from both the N.E.D. album and book are being used to start the N.E.D. Cancer Foundation, an organization founded by Dr. Nagarsheth and his colleagues with a vision on improving the quality of life of patients with gynecologic cancers.

Specialties:

  • obstetrics & gynecology

Affiliation:

  • The Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, May 17 (HealthDay News) -- Too few obstetrics-gynecology residents in the United States receive formal training about menopause, which could lead to care issues for the rapidly growing number of older American women, a new study finds.

    Researchers survey...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, May 15 (HealthDay News) -- Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.

    The news comes just a day after Jolie, 37, revealed in an article published on the editorial page of The Ne...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, May 14 (HealthDay News) -- Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

    Previous research has found that metformin was associ...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, May 14 (HealthDay News) -- Women who have a hysterectomy are not in danger of increasing their risk of cardiovascular disease later in life, a new study says.

    Although earlier research had found higher chances of cardiovascular disease in the years following a hysterectomy, diffe...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, May 14 (HealthDay News) -- Hollywood film star Angelina Jolie announced Tuesday that she has undergone a double mastectomy because she carries a genetic mutation that greatly increases her risk of potentially fatal breast cancer.

    She said she began the process to have both of he...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, May 10 (HealthDay News) -- Higher levels of the hormone estrogen are associated with an increased risk of sudden cardiac death in men and women, a new study suggests.

    Sudden cardiac death can occur when the heart suddenly and unexpectedly stops beating (sudden cardiac arrest). Eac...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, May 8 (HealthDay News) -- Among women who undergo in vitro fertilization (IVF) to become pregnant, there is no difference in delivery rates among those implanted with one prescreened embryo compared to those implanted with two unscreened embryos, new study findings reveal.

    Alt...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, May 7 (HealthDay News) -- Women who use synthetic marijuana during pregnancy can develop symptoms similar to those associated with eclampsia and preeclampsia, according to a new study.

    Although women with these serious prenatal conditions get better after delivery, researchers in...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    THURSDAY, May 2 (HealthDay News) -- The Obama administration announced late Wednesday that it would appeal a federal judge's order to eliminate any age restrictions on who can buy morning-after birth control pills without a prescription.

    The move follows a Tuesday decision by the U.S. Foo...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, April 30 (HealthDay News) -- The U.S. Food and Drug Administration late Tuesday approved the over-the-counter sale of Plan B One-Step, a version of the so-called "morning after" pill, for use as emergency contraception by girls and women aged 15 and older.

    The move ends years of ...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, April 30 (HealthDay News) -- Women with breast implants could run the risk of having breast cancer diagnosed at later stages, when survival might be worse, according to Canadian researchers.

    Breast implants can make it more difficult to diagnose breast cancer early because they b...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, April 19 (HealthDay News) -- More than three years after controversial new guidelines rejected routine annual mammograms for most women, women in all age groups continue to get yearly screenings, a new survey shows.

    In fact, mammogram rates actually increased overall, from 51.9 p...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    THURSDAY, April 18 (HealthDay News) -- In the five years since launching a nationwide human papillomavirus (HPV) vaccination program among girls between the ages of 12 and 26, Australia has seen a huge drop in the number of cases of genital warts, new research reveals.

    Among Australian g...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, April 17 (HealthDay News) -- Women with adequate levels of vitamin D are less likely to develop uterine fibroids than those with insufficient levels, a new study finds.

    Uterine fibroids are noncancerous tumors of the uterus that often cause pain and b...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    SATURDAY, April 6 (HealthDay News) -- A novel but preliminary new treatment for ovarian cancer has apparently produced complete remission for one patient with an advanced form of the disease, researchers are reporting.

    The promising results of a phase 1 clinical trial for the immunotherap...Full Article